Printer Friendly
The Free Library
14,678,926 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

External RNA Controls Consortium Names Testing Sites for Initial Phase of RNA Control Testing.


SANTA CLARA Santa Clara, city, Cuba
Santa Clara (sän`tä klä`rä), city (1994 est. pop. 217,000), capital of Villa Clara prov., central Cuba.
, Calif. -- The External RNA RNA: see nucleic acid.
RNA
 in full ribonucleic acid

One of the two main types of nucleic acid (the other being DNA), which functions in cellular protein synthesis in all living cells and replaces DNA as the carrier of genetic
 Controls Consortium (ERCC ERCC Excision-Repair Cross-Complementing
ERCC Engine(s) Running Crew Change
ERCC Electric Reliability Coordinating Council
ERCC Excision-Repair, Complementing Defective, in Chinese Hamster
) announced today that eight testing sites have registered for the initial phase of the RNA control testing. The initial phase will be conducted by commercial organizations that manufacture microarrays and/or reagents for QRT-PCR QRT-PCR Quantitative Reverse-Transcriptase Polymerase Chain Reaction , as well as one government lab that produces arrays.

The ERCC is an international group of scientists that is working together to define a set of standard RNA controls, protocols and analysis tools to assess intra-platform technical performance for gene expression assays. The eight registered testing sites include Affymetrix, Agilent, Applied Biosystems Applied Biosystems, Inc. (formerly NASDAQ: ABIO) is the original name of a pioneer biotechnology company founded in 1981 in Foster City, California, among the Silicon Valley cities of the southern San Francisco Bay Area. , GE Healthcare GE Healthcare is a $18 billion (USD) unit of General Electric (GE). It employs more than 46,000 people worldwide and is headquartered in Chalfont St. Giles, Buckinghamshire, United Kingdom. GE Healthcare is the first GE business segment headquartered outside the United States. , Illumina, National Institute of Allergy and Infectious Diseases, Qiagen and Roche Molecular Systems. The proposed ERCC Test Plan was published in October 2005 in BMC (BMC Software, Inc., Houston, TX, www.bmc.com) A leading supplier of software that supports and improves the availability, performance, and recovery of applications in complex computing environments.  Genomics. http://www.biomedcentral.com/content/6/1/150.

"The outcome of testing will be identification of a set of controls that work reasonably well on most microarray platforms and by QRT-PCR," said Janet A. Warrington, Ph.D., chairholder of the ERCC and vice president, Emerging Markets and Molecular Diagnostics Research and Development, Affymetrix. "A number of organizations have donated existing controls or created controls for testing and all sequences are being deposited in Genbank."

The ERCC will be accepting applications for other non-manufacturing or non-production sites for control testing in different types of biological samples later this year.

About the External RNA Controls Consortium (ERCC)

The ERCC is an ad-hoc group with approximately 200 members from more than 65 private, public and academic organizations. The group was founded in 2003 to develop a set of external RNA controls, related protocols and analysis tools. The ERCC is open to all interested parties. For more information, please visit: www.imclgs.org and www.nist.gov.

For more information contact: janet_warrington@affymetrix.com.
COPYRIGHT 2006 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Sep 15, 2006
Words:294
Previous Article:New Podcasts from DIRECTV's ``CD USA'' Give Unprecedented Backstage Access to Chart-Topping Artists; Fresh Content Featuring Top Musical Acts Debuts...
Next Article:Ansell Healthcare Renews Commitment to Latex Gloves; Pioneer to Continue Manufacturing Latex Gloves; Plans to Implement Strategies to Address Market...



Related Articles
RNA challenges cancer....(research indicates synthesized RNA strands may keep cancer cells from proliferating)(Brief Article)
Lowering the defenses of bacteria. (researchers attempt to disrupt mechanisms in bacteria that enable them to resist drugs)(Biology)(Brief Article)
Backgrounder: recognizing and diagnosing primary HIV infection. (Backgrounder).
Genetic analysis of viruses associated with emergence of Rift Valley fever in Saudi Arabia and Yemen, 2000-01. (Research).
Detection of SARS coronavirus in patients with suspected SARS.(Laboratory Studies)
Identification of platform-independent gene expression markers of cisplatin nephrotoxicity.(Genomics and Risk Assessment: Mini-Monograph)
The hepatitis C drug development pipeline.(HCV Pipeline)
Global gene expression profiling in whole-blood samples from individuals exposed to metal fumes.(Toxicogenomics)
Toxicogenomics data: the road to acceptance.(Environews / Focus)
Develop quantitative NASBA assay to detect E. coli.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles